BioSig Adds Five New Patent Awards To 100+ Total Patent Portfolio Covering Digital Signal Processing Technology And AI
Portfolio Pulse from Benzinga Newsdesk
BioSig Technologies, Inc. (NASDAQ:BSGM) has been awarded five new utility patents by the U.S. Patent and Trademark Office, expanding its intellectual property portfolio to over 100 patents. The patents cover the company's PURE EP™ digital signal processing technology and AI. The PURE EP™ Platform is currently in a national commercial launch and is part of healthcare systems including Mayo Clinic, Texas Cardiac Arrhythmia Institute, Cleveland Clinic, and Kansas City Heart Rhythm Institute.
November 01, 2023 | 12:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioSig Technologies has been awarded five new patents, strengthening its intellectual property portfolio. This could potentially increase the company's market competitiveness and value.
The addition of new patents to BioSig's portfolio strengthens its market position by protecting its technology from competitors. This could potentially lead to increased investor interest and a rise in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100